Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.57 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.57 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | NOD2 | Q9HC29 | 2/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | PRKDC | P78527 | 1/20 | 0.42 |
| ▸ | SNCA | P37840 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trans-Asarone SCHEMBL528746 | 1.00 | HMGCR (1.00) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| Cis-Asarone SCHEMBL528747 | 1.00 | HMGCR (1.00) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| Trans-Asarone SCHEMBL940800 | 1.00 | HMGCR (1.00) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| Trans-Asarone SCHEMBL29433647 | 1.00 | HMGCR (1.00) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| Trans-Asarone SCHEMBL29268894 | 0.98 | HMGCR (0.95) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| Trans-Asarone SCHEMBL30487992 | 0.88 | CYP3A4 (0.78) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| SCHEMBL13498711 | 0.85 | HMGCR (0.73) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| SCHEMBL13324430 | 0.85 | HMGCR (0.73) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| SCHEMBL12621133 | 0.85 | HMGCR (0.73) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 | |
| SCHEMBL3486261 | 0.83 | HMGCR (0.70) | HMGCRCYP3A4NFE2L2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111778165-B | Aspergillus niger DFY1 and application thereof | 哈尔滨工业大学 | 2022-10-25 | — | — | CN | claimed |
| US-12543733-B2 | Biofumigant composition and a process for the preparation thereof | INSTITUTE OF BIORESOURCES AND SUSTAINABLE DEVELOPMENT (IN) | 2026-02-10 | — | — | US | disclosed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| US-12303488-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-05-20 | — | — | US | disclosed |
| US-20240389586-A1 | BIOFUMIGANT COMPOSITION AND A PROCESS FOR THE PREPARATION THEREOF | INSTITUTE OF BIORESOURCES AND SUSTAINABLE DEVELOPMENT (IN) | 2024-11-28 | — | — | US | disclosed |
| EP-4417252-A2 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | Yuzu LV LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20240216456-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240108676-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-04-04 | — | — | US | disclosed |
| US-11883454-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2024-01-30 | — | — | US | disclosed |
| US-20230405067-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2023-12-21 | — | — | US | disclosed |
| US-20230346739-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC | 2023-11-02 | — | — | US | disclosed |
| US-20230293480-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC | 2023-09-21 | — | — | US | disclosed |
| US-20230293555-A1 | COMPOSITIONS COMPRISING CANNABIDIOL AND FLAVANONES | YUZU LV LLC | 2023-09-21 | — | — | US | disclosed |
| US-11684604-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2023-06-27 | — | — | US | disclosed |
| US-20220387537-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2022-12-08 | — | — | US | disclosed |
| CN-111778165-B | Aspergillus niger DFY1 and application thereof | 哈尔滨工业大学 | 2022-10-25 | — | — | CN | disclosed |
| WO-2022101932-A1 | A NOVEL BIOFUMIGANT COMPOSITION AND A PROCESS FOR THE PREPARATION THEREOF | INSTITUTE OF BIORESOURCES AND SUSTAINABLE DEVELOPMENT (IN) | 2022-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11684604-B2 | Cannabis based therapeutic and method of use | CNR2, CNR1, OPRK1 | HMGCR 857/4885CYP3A4 2613/4885NFE2L2 4098/4885 |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | HMGCR 38/4885CYP3A4 1136/4885NFE2L2 3669/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | HMGCR 406/4885CYP3A4 1979/4885NFE2L2 2023/4885 |
| US-12543733-B2 | Biofumigant composition and a process for the preparation thereof | ERG28, VIP, SI | HMGCR 84/4885CYP3A4 901/4885NFE2L2 4363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.